In an effort to help clinical trial sponsors capitalize on mobile trends and maximize recruitment dollars, BBK Worldwide (BBK) is releasing a suite of advertising tools for mobile applications – designed to increase campaign effectiveness and return on investment. Developed to complement BBK’s existing suite of mobile products and services, this new group of in-app advertising tools creates recruitment opportunities in video, radio, and banner mobile ad networks.
“Mobile advertising has many potential benefits for clinical trial sponsors. Not only does it open doors to untapped audiences of smartphone and tablet users, but it’s very effective when combined with desktop advertising,” comments Lucas Garmon, media strategist, BBK Worldwide. “From a cost-benefit standpoint, the cost per referral is very attractive, making it a savvy consideration for most clinical trial sponsors.”
BBK’s approach to mobile draws upon multiple years of experience and strategic insight into current user trends from its in-house media specialists. To remain competitive in an increasing mobile universe, sponsors must integrate mobile or risk losing out on potential audiences. According to the Pew Internet & American Life Project, 31 percent of cell Internet users surveyed mostly go online using their cell phone, and not using some other device such as a desktop or laptop computer (April 2012).
“Across several campaigns, we’re seeing a tremendous upswing in mobile penetration – including one campaign where we’re seeing that 48 percent of traffic to the study website is resulting from mobile website optimization,” comments Garmon.
BBK is making mobile products and services – and their integration into recruitment initiatives – more attainable for sponsors. The company advocates a strategy-driven multichannel approach. “To remain competitive in today’s marketplace, going mobile is no longer a question but a strategic imperative,” comments Stumm. “Companies lacking a mobile-friendly website drive approximately 61 percent of their mobile traffic to competitors. This is an alarming statistic. If you are weighing the costs to develop a mobile arm to your patient recruitment campaign, it’s important to weigh the risks associated with not having one as well.”
BBK’s suite of mobile recruitment and retention products and services are available for purchase at www.Shop.BBKWorldwide.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.